Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.
作者信息
Réminiac François, Sonneville Romain, Massias Laurent, Chochillon Christian, Wolff Michel
机构信息
Assistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Service de Réanimation Médicale et Infectieuse, Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Assistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Service de Réanimation Médicale et Infectieuse, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
出版信息
Antimicrob Agents Chemother. 2014 Jun;58(6):3568-9. doi: 10.1128/AAC.02719-14. Epub 2014 Apr 14.
Abstract
摘要
相似文献
1
Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.超高剂量卡泊芬净联合伏立康唑治疗中枢神经系统曲霉病：卡泊芬净在脑脊液中有大量渗透。
Antimicrob Agents Chemother. 2014 Jun;58(6):3568-9. doi: 10.1128/AAC.02719-14. Epub 2014 Apr 14.
2
3
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.急性淋巴细胞白血病患者侵袭性鼻窦、气管支气管、肺部和脑曲霉病的长期治疗。
Infection. 2012 Feb;40(1):81-5. doi: 10.1007/s15010-011-0158-9. Epub 2011 Jul 21.
4
Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report.儿童患者合并全身和胸膜内抗真菌治疗曲霉性脓胸的管理：病例报告。
J Infect Public Health. 2018 Mar-Apr;11(2):280-282. doi: 10.1016/j.jiph.2017.04.003. Epub 2017 May 22.
5
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.实验性中枢神经系统曲霉病治疗：疗效、药物水平和定位、免疫组织病理学和毒性。
Antimicrob Agents Chemother. 2012 Aug;56(8):4439-49. doi: 10.1128/AAC.06015-11. Epub 2012 Jun 11.
6
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.播散性侵袭性曲霉病伴脑部受累，经卡泊芬净和伏立康唑成功治疗。
Infection. 2007 Oct;35(5):364-6. doi: 10.1007/s15010-007-6165-1. Epub 2007 Aug 25.
7
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.在侵袭性肺曲霉病的小鼠模型中进行的治疗和毒理学研究。
Med Mycol. 2011 Nov;49(8):834-47. doi: 10.3109/13693786.2011.577822. Epub 2011 May 4.
8
Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.侵袭性气管支气管曲霉病所致气道梗阻
Am J Med Sci. 2016 Aug;352(2):218. doi: 10.1016/j.amjms.2015.11.025. Epub 2016 May 11.
9
Late aspergilloma of a renal allograft without need for operative management: a case report and review of the literature.肾移植术后晚期曲霉菌瘤无需手术治疗：一例报告并文献复习
Transpl Infect Dis. 2016 Apr;18(2):261-5. doi: 10.1111/tid.12495. Epub 2016 Feb 18.
10
Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl.一名6个月大的白血病女童治疗脑曲霉病时需要高剂量伏立康唑且要有脑脊液穿透的记录。
J Chemother. 2017 Feb;29(1):42-44. doi: 10.1179/1973947815Y.0000000009. Epub 2016 May 24.
引用本文的文献
1
Antifungal Drugs: Special Problems Treating Central Nervous System Infections.抗真菌药物：治疗中枢神经系统感染的特殊问题
J Fungi (Basel). 2019 Oct 11;5(4):97. doi: 10.3390/jof5040097.
2
Chronic Meningitis.慢性脑膜炎
Continuum (Minneap Minn). 2018 Oct;24(5, Neuroinfectious Disease):1298-1326. doi: 10.1212/CON.0000000000000664.
本文引用的文献
1
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.成人危重症患者的脑曲霉病：来自 AspICU 队列的 10 例患者的描述性报告。
Int J Antimicrob Agents. 2014 Feb;43(2):165-9. doi: 10.1016/j.ijantimicag.2013.10.012. Epub 2013 Nov 15.
2
Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases.曲霉性脑膜炎：中枢神经系统曲霉病的罕见临床表现。病例报告和 92 例病例回顾。
J Infect. 2013 Mar;66(3):218-38. doi: 10.1016/j.jinf.2012.11.003. Epub 2012 Nov 21.
3
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.实验性中枢神经系统曲霉病治疗：疗效、药物水平和定位、免疫组织病理学和毒性。
Antimicrob Agents Chemother. 2012 Aug;56(8):4439-49. doi: 10.1128/AAC.06015-11. Epub 2012 Jun 11.
4
Efficacy and safety of current drug therapies for invasive aspergillosis.当前侵袭性曲霉菌病药物治疗的疗效和安全性。
Pharmacology. 2011;88(3-4):213-24. doi: 10.1159/000331860. Epub 2011 Oct 6.
5
Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasis.卡泊芬净在中枢神经系统念珠菌病幼年小鼠模型中的疗效。
Antimicrob Agents Chemother. 2011 Jul;55(7):3491-7. doi: 10.1128/AAC.01328-10. Epub 2011 Apr 25.
6
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.伏立康唑治疗 192 例真菌性中枢神经系统感染的疗效：回顾性分析。
Infection. 2011 Jun;39(3):201-10. doi: 10.1007/s15010-011-0108-6. Epub 2011 Apr 22.
7
Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.通过对大量血清样本进行实时PCR检测循环烟曲霉DNA，可改善对接受血液学监测的高危成年患者侵袭性曲霉病的早期诊断。
J Clin Microbiol. 2008 Nov;46(11):3772-7. doi: 10.1128/JCM.01086-08. Epub 2008 Sep 24.
8
A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid.1例侵袭性中枢神经系统曲霉病患者接受米卡芬净治疗并监测脑脊液中米卡芬净浓度。
Scand J Infect Dis. 2007;39(4):344-6. doi: 10.1080/00365540600951333.
9
Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.危重症患者的脑曲霉病：两例成功的药物治疗病例
Intensive Care Med. 2005 May;31(5):738-42. doi: 10.1007/s00134-005-2605-5. Epub 2005 Mar 22.
Zotero 插件